logo

CNTB

Connect BiopharmaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

CNTB Profile

Connect Biopharma Holdings Limited

A biotech company developing therapies for inflammatory diseases and autoimmune disorders

Pharmaceutical
11/23/2015
03/19/2021
NASDAQ Stock Exchange
62
12-31
Common stock
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO, CALIFORNIA 92130
Development of a new generation of immunomodulators for severe autoimmune diseases and inflammation
Connect Biopharma Holdings Limited, incorporated in the Cayman Islands on November 23, 2015, is a clinical-stage biopharmaceutical company dedicated to the discovery and development of a new generation of immunomodulators for severe autoimmune diseases and inflammation. The Group has leveraged its expertise in T-cell regulatory biology to build a portfolio of drug candidates consisting of small molecules and antibodies targeting key pathways of inflammation.